Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug
Mandy Juárez, Alejandro Schcolnik‐Cabrera, Guadalupe Domínguez-Gómez, Alma Chávez‐Blanco, José Díaz‐Chávez, Alfonso Dueñas‐González
Topics & Concepts
IvermectinDU145PharmacologyCell cyclePopulationViability assayMedicineAntiparasitic agentCancerCellCancer researchBiologyCancer cellInternal medicineVeterinary medicineGeneticsLNCaPEnvironmental healthParasitic Diseases Research and TreatmentHelminth infection and controlParasites and Host Interactions